[link|313|Hiroshima Biomedical Co website] is a startup company located in Hiroshima. The company was founded in 2007 as a spin-off of Hiroshima University. It develops and sells chicken monoclonal antibodies, transgenic chicken and eggs. Capital is 10 million Yen (~ 89.000 €). It is located in the Hiroshima University Industry Cooperation Center and has 5 employees. President is Mr Haruo MATSUDA.